▶ 調査レポート

世界のホモ接合型家族性高コレステロール血症の治療市場2019
• 英文タイトル：Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界のホモ接合型家族性高コレステロール血症の治療市場2019 / Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019 / QYR9N1684資料のイメージです。• レポートコード：QYR9N1684
• 出版社/出版日：QYResearch / 2019年6月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥600,000 (USD4,000)▷ お問い合わせ
  Enterprise License￥1,200,000 (USD8,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、ホモ接合型家族性高コレステロール血症の治療の世界市場について調査・分析し、ホモ接合型家族性高コレステロール血症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・ホモ接合型家族性高コレステロール血症の治療市場概要
・ホモ接合型家族性高コレステロール血症の治療のメーカー別販売量・メーカー別シェア
・ホモ接合型家族性高コレステロール血症の治療の種類別販売量（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）
・ホモ接合型家族性高コレステロール血症の治療の用途別販売量（診療所、病院、その他）
・ホモ接合型家族性高コレステロール血症の治療の地域別販売量・市場シェア
・ホモ接合型家族性高コレステロール血症の治療の米国市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療のヨーロッパ市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療の中国市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療の日本市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療の東南アジア市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療のインド市場規模（2014年-2019年）
・ホモ接合型家族性高コレステロール血症の治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・ホモ接合型家族性高コレステロール血症の治療のコスト分析
・ホモ接合型家族性高コレステロール血症の治療販売チャネル、流通業者、顧客
・ホモ接合型家族性高コレステロール血症の治療の世界市場動向・機会・成長要因・課題
・ホモ接合型家族性高コレステロール血症の治療の種類別世界市場予測（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）
・ホモ接合型家族性高コレステロール血症の治療の用途別世界市場予測（診療所、病院、その他）
・ホモ接合型家族性高コレステロール血症の治療の米国市場予測（2019年-2025年）
・ホモ接合型家族性高コレステロール血症の治療のヨーロッパ市場予測（2019年-2025年）
・ホモ接合型家族性高コレステロール血症の治療の中国市場予測（2019年-2025年）
・ホモ接合型家族性高コレステロール血症の治療の日本市場予測（2019年-2025年）
・ホモ接合型家族性高コレステロール血症の治療の東南アジア市場予測（2019年-2025年）
・ホモ接合型家族性高コレステロール血症の治療のインド市場予測（2019年-2025年）
...

The global Homozygous Familial Hypercholesterolemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Homozygous Familial Hypercholesterolemia Treatment market status and forecast, categorizes the global Homozygous Familial Hypercholesterolemia Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others

Segment by Application
Clinic
Hospital
Others

レポート目次

Table of Contents

Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019
1 Homozygous Familial Hypercholesterolemia Treatment Market Overview
1.1 Homozygous Familial Hypercholesterolemia TreatmentProduct Overview
1.2 Homozygous Familial Hypercholesterolemia Treatment Segment by Type
1.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Comparison by Types (2014-2025)
1.2.2 AEM-2802
1.2.3 AEM-2814
1.2.4 Alirocumab
1.2.5 Evinacumab
1.2.6 Others
1.3 Homozygous Familial Hypercholesterolemia Treatment Segment by Application
1.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Comparison by Application (2014-2025)
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Homozygous Familial Hypercholesterolemia Treatment Market by Region
1.4.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.4.3 Europe Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.4.4 China Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.4.5 Japan Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.4.7 India Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
1.5 Global Homozygous Familial Hypercholesterolemia Treatment Sales and Revenue (2014-2025)
1.5.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue and Growth Rate (2014-2025)

2 Homozygous Familial Hypercholesterolemia Treatment by Company, Region, Type and Application
2.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Competition by Companies
2.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Homozygous Familial Hypercholesterolemia Treatment Sales and Revenue by Region
2.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Homozygous Familial Hypercholesterolemia Treatment Sales and Revenue by Type
2.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Homozygous Familial Hypercholesterolemia Treatment Sales by Application

3 United States Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
3.1 United States Homozygous Familial Hypercholesterolemia Treatment Sales and Revenue (2014-2019)
3.1.1 United States Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
3.2 United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
3.3 United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
3.4 United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

4 Europe Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
4.1 Europe Homozygous Familial Hypercholesterolemia Treatment Sales and Value (2014-2019)
4.1.1 Europe Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
4.2 Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
4.3 Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
4.4 Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

5 China Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
5.1 China Homozygous Familial Hypercholesterolemia Treatment Sales and Revenue (2014-2019)
5.1.1 China Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
5.1.2 China Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
5.2 China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
5.3 China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
5.4 China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

6 Japan Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
6.1 Japan Homozygous Familial Hypercholesterolemia Treatment Sales and Value (2014-2019)
6.1.1 Japan Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
6.2 Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
6.3 Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
6.4 Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

7 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
7.1 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
7.2 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
7.3 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
7.4 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

8 India Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price
8.1 India Homozygous Familial Hypercholesterolemia Treatment Sales and Value (2014-2019)
8.1.1 India Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
8.1.2 India Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Homozygous Familial Hypercholesterolemia Treatment Price Trend (2014-2019)
8.2 India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company
8.3 India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type
8.4 India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Homozygous Familial Hypercholesterolemia Treatment Business
9.1 CymaBay Therapeutics Inc
9.1.1 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.1.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.1.3 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Daewoong Co Ltd
9.2.1 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.2.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.2.3 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Gemphire Therapeutics Inc
9.3.1 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.3.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.3.3 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 LipimetiX Development Inc
9.4.1 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.4.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.4.3 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Regeneron Pharmaceuticals Inc
9.5.1 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.5.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.5.3 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 RegenxBio Inc
9.6.1 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
9.6.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.6.3 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 The Medicines Company
9.7.1 The Medicines Company Production Sites and Area Served
9.7.2 Homozygous Familial Hypercholesterolemia Treatment Specification and Application
9.7.3 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
…

10 Homozygous Familial Hypercholesterolemia Treatment Maufacturing Cost Analysis
10.1 Homozygous Familial Hypercholesterolemia Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Homozygous Familial Hypercholesterolemia Treatment
10.4 Homozygous Familial Hypercholesterolemia Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Homozygous Familial Hypercholesterolemia Treatment Distributors List
11.3 Homozygous Familial Hypercholesterolemia Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Homozygous Familial Hypercholesterolemia Treatment Market Forecast
13.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue and Price Forecast
13.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Homozygous Familial Hypercholesterolemia Treatment Price Trend Forecast (2019-2025)
13.2 Global Homozygous Familial Hypercholesterolemia Treatment Forecast by Region
13.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Homozygous Familial Hypercholesterolemia Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Homozygous Familial Hypercholesterolemia Treatment Forecast by Type
13.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Homozygous Familial Hypercholesterolemia Treatment Price Forecast by Type (2019-2025)
13.4 Global Homozygous Familial Hypercholesterolemia Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Homozygous Familial Hypercholesterolemia Treatment Sales (Jan)
Figure Homozygous Familial Hypercholesterolemia Treatment Product Picture
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Types in 2018
Figure AEM-2802 Product Picture
Figure AEM-2814 Product Picture
Figure Alirocumab Product Picture
Figure Evinacumab Product Picture
Figure Others Product Picture
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Application in 2018
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Table Global Market Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales by Company in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Company (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Company in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) by Company in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Company (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Company in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Region (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Region in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Region (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region In 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Type (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate by Type in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Type (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate by Type in 2018
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Application (2014-2019)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure United States Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure China Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table China Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table China Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table China Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Figure India Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Trend (2014-2019)
Table India Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Company (2014-2019)
Table India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company (2014-2019)
Figure India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Company in 2018
Table India Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2014-2019)
Table India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2014-2019)
Figure India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type in 2018
Table India Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2014-2019)
Table India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2014-2019)
Figure India Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application in 2018
Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Specification and Application
Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales Growth Rate (2014-2019)
Figure The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Revenue Share in International Market (2014-2019)
Figure The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Homozygous Familial Hypercholesterolemia Treatment
Figure Manufacturing Process Analysis of Homozygous Familial Hypercholesterolemia Treatment
Figure Homozygous Familial Hypercholesterolemia Treatment Industrial Chain Analysis
Table Homozygous Familial Hypercholesterolemia Treatment Distributors List
Table Homozygous Familial Hypercholesterolemia Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Regions in 2025
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Homozygous Familial Hypercholesterolemia Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の家族性腺腫性ポリポーシス治療市場2019
    Global Familial Adenomatous Polyposis Treatment Sales Market Report 2019
    QYR9N0916 2019年6月10日 100Pages
    本調査レポートでは、家族性腺腫性ポリポーシス治療の世界市場について調査・分析し、家族性腺腫性ポリポーシス治療のメーカー別販売量、市場シェア分析、種類別販売分析（イコサペント、塩酸エルフロニチン、アスピリン、CEQ-508、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロ...
  • 世界の家族性アミロイドポリニューロパチー市場：市場規模・現状・予測
    Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2019-2025
    QYR9N7193 2019年6月14日 94Pages
    当資料は、家族性アミロイドポリニューロパチーのグローバル市場について調査・分析したレポートで、種類別（FAP-I
    、FAP-II
    、FAP-III
    、FAP-IV
    ）、用途別（病院と診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...
  • 世界の脂質障害治療市場2019
    Global Lipid Disorder Treatment Sales Market Report 2019
    QYR9N2276 2019年6月10日 105Pages
    本調査レポートでは、脂質障害治療の世界市場について調査・分析し、脂質障害治療のメーカー別販売量、市場シェア分析、種類別販売分析（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他の薬）、用途別販売分析（小売薬局、病院薬局、オンライン薬局）、地域別販売分析（米国、...
  • 世界の異染性白質ジストロフィー（MLD）治療市場2019
    Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Report 2019
    QYR9N2558 2019年6月10日 101Pages
    本調査レポートでは、異染性白質ジストロフィー（MLD）治療の世界市場について調査・分析し、異染性白質ジストロフィー（MLD）治療のメーカー別販売量、市場シェア分析、種類別販売分析（AGT-183、DUOC-01、GSK-2696274、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析...
  • 世界の血漿プロテアーゼC1阻害剤治療市場2019
    Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2019
    QYR9N3459 2019年6月13日 101Pages
    本調査レポートでは、血漿プロテアーゼC1阻害剤治療の世界市場について調査・分析し、血漿プロテアーゼC1阻害剤治療のメーカー別販売量、市場シェア分析、種類別販売分析（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））、用途別販売分析（病院薬...
  • 世界の末期腎臓病治療市場2019
    Global End-Stage Kidney Disease Treatment Sales Market Report 2019
    QYR9N0792 2019年6月10日 105Pages
    本調査レポートでは、末期腎臓病治療の世界市場について調査・分析し、末期腎臓病治療のメーカー別販売量、市場シェア分析、種類別販売分析（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、イ...
  • 世界の眼の炎症治療市場2019
    Global Ocular Inflammation Treatment Sales Market Report 2019
    QYR9N2996 2019年6月13日 105Pages
    本調査レポートでは、眼の炎症治療の世界市場について調査・分析し、眼の炎症治療のメーカー別販売量、市場シェア分析、種類別販売分析（免疫抑制剤、モノクローナル抗体、コルチコステロイド、環状麻薬、抗生物質、その他）、用途別販売分析（小売薬局、病院薬局、オンライン薬局、ドラッグストア）、地域別販売分析（米国...
  • 世界のミトコンドリアミオパチーの診断と治療市場2019
    Global Mitochondrial Myopathy Diagnosis & Treatment Sales Market Report 2019
    QYR9N2675 2019年6月10日 102Pages
    本調査レポートでは、ミトコンドリアミオパチーの診断と治療の世界市場について調査・分析し、ミトコンドリアミオパチーの診断と治療のメーカー別販売量、市場シェア分析、種類別販売分析（遺伝子検査、筋肉生検）、用途別販売分析（支持療法、ターゲット療法）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の家族性腺腫性ポリポーシス治療市場2019世界の家族性腺腫性ポリポーシス治療市場2019 The global Familial Adenomatous Polyposis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Familial Adenomatous Polyposis Treatment market status and forecast, categorizes the globa…
  • 世界の家族性アミロイドポリニューロパチー市場：市場規模・現状・予測世界の家族性アミロイドポリニューロパチー市場：市場規模・現状・予測 Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle.Globally, development of new drug…
  • 世界のウィルムス腫瘍治療市場2019世界のウィルムス腫瘍治療市場2019 The global Wilms' Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Wilms' Tumor Treatment market status and forecast, categorizes the global Wilms' Tumor Treatment market size…
  • 世界の異染性白質ジストロフィー（MLD）治療市場2019世界の異染性白質ジストロフィー（MLD）治療市場2019 The global Metachromatic Leukodystrophy (MLD) Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Metachromatic Leukodystrophy (MLD) Treatment market status and forecast, categorizes t…
  • 世界の血漿プロテアーゼC1阻害剤治療市場2019世界の血漿プロテアーゼC1阻害剤治療市場2019 The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Pl…